Oxcarbazepine Tablet, Film Coated
Product Images NDC 71335-2548

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 71335-2548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352548)

Label (Lbl713352548)
This text is a product description for Oxcarbazepine tablets. Each film-coated tablet contains 300 mg of Oxcarbazepine and FD&C Yellow No. 5. The medication should be kept out of children's reach and stored at 20° to 25°C. Dispensing should be done in a tight container, and dosage information can be found by scanning the QR code on the package insert. Manufactured by Annora Pharma Pvt. Ltd., the tablets come in a package of 30.*
FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)
This text provides information on a log-rank test result with a p-value of 0.0001. The data table presented includes time on trial from Day 2 to Day 11 for the treatment group "Oxcarbarspine."*
FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)
Days from 1st dose to 1st seizure in two treatment groups, Oxcarbazepine and Placebo, are being evaluated in the given data. The graph seems to show data points at different time intervals, and it can be used to analyze the efficacy of the treatments in reducing or delaying seizures.*
FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)
This is a result of a log-rank test with a p-value of 0.0001. The data shows time to exit in days for two treatment groups: HIGH and LOW. The numerical values represent time points for each group.*
FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)
This text provides the results of a log-rank test with a p-value of 0.0001. The data also includes a graph showing time to exit in days for two treatment groups, labeled as HIGH and LOW.*
FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

FDA Label Image

Oxcarbazipinetabcamberlogo1 (Oxcarbazipinetabcamberlogo1)

FDA Label Image

Oxcarbazipinetabcamberlogo2 (Oxcarbazipinetabcamberlogo2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.